Drury P L
Diabetologia. 1983 Jan;24(1):1-9. doi: 10.1007/BF00275938.
The epidemiology, pathogenesis, significance and management of hypertension in diabetic subjects are discussed. In Type 1 diabetes the presence of diastolic hypertension is closely related to the presence of diabetic nephropathy, from the stage of persistent proteinuria onwards. There may also be some elevation of systolic pressure. The apparent increased prevalence of hypertension in Type 2 diabetes is largely explicable, directly or indirectly, by obesity but there may be an excess of systolic hypertension among elderly patients. Hypertension in the diabetic population is associated with an increased incidence of both microvascular and macrovascular complications, but whether the high blood pressure is causal is not clear. The possible roles of sodium and insulin, the renin-angiotensin system, catecholamines and physical factors are explored. All current antihypertensive agents have additional limitations and disadvantages when used in diabetic patients: diuretics and beta-blockers are probably the initial drugs of choice. Only in the case of diabetic nephropathy is there yet reasonable evidence of antihypertensive treatment reducing the rate of progression of the disease.
本文讨论了糖尿病患者高血压的流行病学、发病机制、意义及治疗。在1型糖尿病中,从持续性蛋白尿阶段起,舒张压升高与糖尿病肾病的存在密切相关。收缩压也可能有所升高。2型糖尿病中高血压患病率明显增加,很大程度上可直接或间接归因于肥胖,但老年患者中收缩期高血压可能更为多见。糖尿病患者的高血压与微血管和大血管并发症的发生率增加相关,但高血压是否为病因尚不清楚。文中探讨了钠、胰岛素、肾素 - 血管紧张素系统、儿茶酚胺及物理因素的可能作用。目前所有的抗高血压药物在用于糖尿病患者时都有额外的局限性和缺点:利尿剂和β受体阻滞剂可能是首选的初始药物。只有在糖尿病肾病的情况下,才有合理证据表明抗高血压治疗可降低疾病进展速度。